Serge Belanger


Needham Bullish on Aerie Pharmaceuticals Inc (AERI) Despite NDA Filing Delay for Rhopressa

Needham’s Serge Belanger has reiterated his Buy rating on Aerie Pharma (NASDAQ: AERI) despite a stalled manufacturing pre-inspection that has caused the firm to delay …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts